Adlexa uses multi-agent AI to screen GLP-1 weight loss, peptide funnels, and telehealth ad copy before you hit publish. Detect absolute claims, trademark violations, and get compliant rewrites in seconds.
Psychologically, agencies underestimate compliance risk until their primary Business Manager gets disabled.
Using unapproved GLP-1 brand names (Ozempic®, Wegovy®, Mounjaro®) or implied guarantees triggers automated platform flags that permanently blacklist pixel data.
Compounded semaglutide & tirzepatide claims without individualized doctor disclaimers violate 21 U.S.C. 353a, exposing clinics to federal warning letters.
Audits your assets before you publish. Pinpoints the exact violation type, cites the law, and rewrites the copy to pass moderation on the first review.
Scan live landing page URLs, raw ad copy strings, or upload image creatives. Adlexa extracts visuals and text to evaluate end-to-end user journeys.
Interactive chat with Adlexa AI dynamically leverages advanced multimodal reasoning for custom legal rewrites and objection reframing.
Direct Live Search Grounding continuously monitors latest FDA warning letters, LegitScript policies, and Meta guidelines in real-time.
Track score trajectory across all scans with interactive Recharts data visualizations and instant one-click report restoration.
"Guaranteed 25 lbs weight loss in 30 days with Generic Ozempic"
"Physician-prescribed compounded semaglutide. Individual results vary. Requires online telehealth consultation."
Every plan includes a 3-day free trial. If you don't cancel before day 3, automatic billing activates smoothly with zero service interruption.
For solo media buyers and niche telehealth affiliates.
For clinics & health performance marketing agencies.
For national telehealth networks & compounding pharmacies.
Peer-audited regulatory playbooks, quantitative risk tables, and platform compliance guidelines to protect healthcare ad accounts from permanent bans.
How high-velocity telemedicine advertisers trigger stealth shadowbans and permanent Business Manager disabled statuses, with step-by-step remediation.
FDA 503A human drug compounding requirements, Lanham Act trademark rules against brand naming, and Meta personal health attribute limits.
Complete merchant checklist, pharmacy supply chain audits, and policy guidelines required to run telemedicine ads on Google and Meta.
Schedule III controlled substance restrictions, FDA black-box cardiovascular warning mandates, and compliant ED / Enclomiphene copy rules.
Direct, quantitative answers to natural language questions regarding before-and-after imagery, prescription drug ad rules, and FDA disclaimers.
Screen ad copy, OCR video frames, inspect landing page intake forms, and receive automated compliant rewrites in real time.
Everything you need to know about our compliance guarantee.
Join hundreds of health media buyers who run pre-flight compliance audits before launching campaigns.